SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 5th, 2023 • One World Products, Inc. • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 23, 2023, by and between ONE WORLD PRODUCTS, INC., a Nevada corporation, with headquarters located at 6605 Grand Montecito Pkwy., Suite 100, Las Vegas, NV 89149 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 (the “Buyer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 7th, 2022 • One World Products, Inc. • Pharmaceutical preparations • Nevada
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 1, 2022, by and between ONE WORLD PRODUCTS, INC., a Nevada corporation (the “Company”), and TYSADCO PARTNERS, LLC, a Delaware limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 5th, 2023 • One World Products, Inc. • Pharmaceutical preparations
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of June 23, 2023, by and between ONE WORLD PRODUCTS, INC., a Nevada corporation, with headquarters located at 6605 Grand Montecito Pkwy., Suite 100, Las Vegas, NV 89149 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 (the “Investor”).
COMMON STOCK PURCHASE WARRANT ONE WORLD PHARMA, INC.Common Stock Purchase Warrant • September 27th, 2021 • One World Pharma, Inc. • Pharmaceutical preparations • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $750,000.00 8% promissory note to the Holder (as defined below) of even date) (the “Note”), AJB Capital Investments, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from One World Pharma Inc. Inc., a Nevada corporation (the “Company”), up to 1,500,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 24, 2021, by and among the
SECURITY AGREEMENTSecurity Agreement • September 27th, 2021 • One World Pharma, Inc. • Pharmaceutical preparations • Wyoming
This SECURITY AGREEMENT (this “Agreement”) made and effective as of September 24, 2021, is executed by and between ONE WORLD PHARMA, INC., a Nevada corporation (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the “Secured Party”).
One World Pharma, Inc. and OWP Ventures, Inc. Pro Forma Financial Information (Unaudited) For the Year Ended December 31, 2018One World Pharma, Inc. • July 12th, 2019 • Pharmaceutical preparations
On February 21, 2019, One World Pharma, Inc. (“the Company”) entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma, SAS (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 shares of our common stock; (b) options to purchase 825,000 shares of common stock of OWP Ventures at an exercise price of $0.50 automatically converted into options to purchase 825,000 shares of our common stock at an exercise price of $0.50; (c) the outstanding principal and interest under a $300,000 convertible note issued by OWP Ventures bec
PURCHASE AGREEMENTPurchase Agreement • September 7th, 2022 • One World Products, Inc. • Pharmaceutical preparations • Nevada
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of September 1, 2022, is entered into by and between ONE WORLD PRODUCTS, INC., a Nevada corporation (the “Company”), and TYSADCO PARTNERS, LLC, a Delaware limited liability company (the “Investor”).
ContractShare Purchase Agreement • December 10th, 2019 • One World Pharma, Inc. • Pharmaceutical preparations
Share Purchase Agreement This Share Purchase Agreement (the “Agreement”) is made by and between: (i) OWP Ventures, Inc., a company duly incorporated and validly existing under the laws of the State of Delaware, Unites States of America, domiciled in 2110 E. 5th Avenue, Ronkonkoma, NY 11779, represented herein by Craig Matthew Ellins, of legal age, identified with Passport No. 464997617issued by the United States of America, who acts in her capacity as Chief Executive Officer (the “Purchaser”); and (i) Engineering Consulting S.A.S., a company duly incorporated and validly existing under the laws of Colombia, with Tax Identification Number (NIT) 900.525.617-2, domiciled in the city of Bogota, D.C., represented herein by Paola Fernanda Sánchez González, of legal age, identified with Colombian citizenship card No. 1.101.174.745 issued in Puente Nacional Santander, who acts in her capacity as Legal Representative; and (ii) Lina María Isaza Díaz, of legal age, identified with Colombian citiz
CONTRACT OF LEASE OF PROPERTIES Page 3 of 9Contract of Lease • May 16th, 2022 • One World Products, Inc. • Pharmaceutical preparations
THE LESSOR together with THE LESSEE hereinafter THE PARTIES, we have agreed to enter into this Lease contract, hereinafter THE CONTRACT, which will be governed by the rules that regulate the matter according to the use of the property, especially by the following clauses and taking into account the following:
OWP VENTURES, INC. CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTConvertible Promissory Note Purchase Agreement • February 25th, 2019 • One World Pharma, Inc. • Services-prepackaged software • Delaware
THIS CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of January 14, 2019 (the “Effective Date”), is entered into by and among OWP Ventures, Inc., a Delaware corporation (the “Company”), and the undersigned investors (individually an “Investor” and collectively, the “Investors”).
ONE WORLD PHARMA, INC. Option Agreement2019 Stock Incentive Plan • February 25th, 2020 • One World Pharma, Inc. • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, One World Pharma, Inc. (the “Company”) has granted you an option under its 2019 Stock Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
AGREEMENT AND PLAN OF MERGER by and among ONE WORLD PHARMA, INC., OWP MERGER SUBSIDIARY, INC. and OWP VENTURES, INC. February 21, 2019Agreement and Plan of Merger • February 25th, 2019 • One World Pharma, Inc. • Services-prepackaged software • Delaware
THIS AGREEMENT AND PLAN OF MERGER is entered into as of February 21, 2019 by and among ONE WORLD PHARMA, INC., a Nevada corporation (“Parent”), OWP MERGER SUBSIDIARY, INC, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and OWP VENTURES, INC., a Delaware corporation (the “Company”).
securities purchase AGREEMENTSecurities Purchase Agreement • February 8th, 2021 • One World Pharma, Inc. • Pharmaceutical preparations • Nevada
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), between One World Pharma, Inc., a Nevada corporation (the “Company”), and ISIAH International, LLC (the “Investor”), is made and entered into as of February 7, 2021.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 7th, 2022 • One World Products, Inc. • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 1, 2022, is entered into by and between One World Products, Inc., a Nevada corporation, (the “Company”), and Tysadco Partners, LLC, a Delaware limited liability company (the “Buyer”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • June 9th, 2020 • One World Pharma, Inc. • Pharmaceutical preparations • Nevada
This Agreement (this “Agreement”) is made as of June 3, 2020, by and between ONE WORLD PHARMA, INC., a Nevada corporation (the “Company”), and CRAIG ELLINS (“Ellins”).
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 30th, 2021 • One World Pharma, Inc. • Pharmaceutical preparations • Nevada
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated this 11th day of October, 2021, by and between One World Pharma, Inc., a Nevada corporation (“OW Pharma”), and One World Products, Inc., a Nevada corporation and a wholly-owned subsidiary of OW Pharma (“OW Products”), is made with respect to the following facts.
Service AgreementService Agreement • February 25th, 2019 • One World Pharma, Inc. • Services-prepackaged software • California
This Service Agreement (the “Agreement”) is by and between Integrity Media, Inc., a Nevada corporation (“IMI”), and One World Pharma, Inc. (OWP), a Nevada corporation (the “COMPANY”). This Agreement is made effective as of February 18, 2019 (the “Effective Date”). IMI and the COMPANY are referred to herein individually as a “Party” and collectively as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • February 25th, 2019 • One World Pharma, Inc. • Services-prepackaged software • Nevada
THIS CONSULTING AGREEMENT (“Agreement”) is made as of February 8, 2019 between OWP Ventures, Inc., a Delaware corporation (“Company”), and Bruce Raben (“Consultant”, and together with Company, the “Parties”).
